Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeLung cancer

      Lung cancer

      What is a gene mutation?

      Experts aren’t sure why, but sometimes changes in DNA can trigger cancer to grow and spread. For DNA Day learn all about gene mutations—and Johnson & Johnson’s work developing new therapies to target these specific types of cancer.

      Could we be on our way to eliminating cancer for good?

      What once seemed like an out-of-reach goal may soon be within our grasp. For National Cancer Research Month, take an in-depth look at how Johnson & Johnson is working toward its vision of helping create a world without cancer.

      By the numbers: Who gets lung cancer?

      Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.

      “No one would believe me when I suspected I had lung cancer”

      Learn about one patient’s journey toward getting an accurate diagnosis—and why it’s crucial to always advocate for your health.

      By the numbers: Helping to reduce disparities in cancer care

      For World Health Day, learn how Johnson & Johnson’s commitment to Diversity, Equity and Inclusion is helping to deliver transformational cancer treatments and solutions that reach the patients who need them most.

      How data science is ushering in a new era of modern medicine

      Algorithms, artificial intelligence, machine learning and other technologies are transforming the way physicians identify, treat and manage diseases. Here’s how Johnson & Johnson is putting the latest tools to work.

      4 questions for a data science innovator

      Hidden in large amounts of digital information—such as anonymized medical records—may be the keys to transforming the future of healthcare. Troy C. Sarich, Ph.D., Johnson & Johnson’s Chief Commercial Data Science Officer, shares how the company is carefully collecting, analyzing and harnessing this information to improve the health of people everywhere.

      “Our goal is to prevent lung cancer from happening in the first place”

      Artificial intelligence-enabled mobile screening units. Nasal swab genomic tests. Diagnostics that pair the right treatment with the right patient. For Healthy Lung Month, Johnson & Johnson researchers share the progress that’s being made to thwart the #1 cancer killer.

      Johnson & Johnson executive Jennifer Taubert named to 2021 Fortune Most Powerful Women in Business list

      It’s the sixth year in a row that the company leader has placed on the list, which honors 50 women at the top of their industries.

      The quest to help patients with a deadly type of lung cancer

      Despite obstacles and setbacks, these researchers vowed to never give up working to develop a new treatment for non-small cell lung cancer. For Lung Cancer Awareness Month, they share their journey.